360 related articles for article (PubMed ID: 2535688)
1. NIH conference. Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut.
Gorden P; Comi RJ; Maton PN; Go VL
Ann Intern Med; 1989 Jan; 110(1):35-50. PubMed ID: 2535688
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of SMS 201-995. Long-term treatment in gut neuroendocrine tumours, efficacy of oral administration, and possible use in non-tumoural inappropriate TSH hypersecretion.
Williams G; Anderson JV; Williams SJ; Bloom SR
Acta Endocrinol Suppl (Copenh); 1987; 286():26-36. PubMed ID: 2892335
[TBL] [Abstract][Full Text] [Related]
3. Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors.
Maton PN; Gardner JD; Jensen RT
Dig Dis Sci; 1989 Mar; 34(3 Suppl):28S-39S. PubMed ID: 2537716
[TBL] [Abstract][Full Text] [Related]
4. Non-pituitary actions of somatostatin. A review on the therapeutic role of SMS 201-995 (sandostatin).
Lamberts SW
Acta Endocrinol Suppl (Copenh); 1986; 276():41-55. PubMed ID: 2875590
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin analogue (SMS 201-995) in the management of gastroenteropancreatic tumors and diarrhea syndromes.
Vinik AI; Tsai ST; Moattari AR; Cheung P; Eckhauser FE; Cho K
Am J Med; 1986 Dec; 81(6B):23-40. PubMed ID: 2879447
[TBL] [Abstract][Full Text] [Related]
6. Acromegaly from ectopic growth hormone-releasing hormone secretion by a malignant carcinoid tumor. Successful treatment with long-acting somatostatin analogue SMS 201-995.
Barkan AL; Shenker Y; Grekin RJ; Vale WW
Cancer; 1988 Jan; 61(2):221-6. PubMed ID: 2891432
[TBL] [Abstract][Full Text] [Related]
7. Acromegaly.
Bloom SR
Am J Med; 1987 May; 82(5B):88-91. PubMed ID: 2884882
[TBL] [Abstract][Full Text] [Related]
8. A guide to the clinical use of the somatostatin analogue SMS 201-995 (Sandostatin).
Lamberts SW
Acta Endocrinol Suppl (Copenh); 1987; 286():54-66. PubMed ID: 2892338
[TBL] [Abstract][Full Text] [Related]
9. Clinical review 23: The use of the long-acting somatostatin analog octreotide in the treatment of gut neuroendocrine tumors.
Wynick D; Bloom SR
J Clin Endocrinol Metab; 1991 Jul; 73(1):1-3. PubMed ID: 1646213
[TBL] [Abstract][Full Text] [Related]
10. Reduction of pituitary size by the somatostatin analogue SMS 201-995 in a patient with an islet cell tumour secreting growth hormone releasing factor.
Wilson DM; Hoffman AR
Acta Endocrinol (Copenh); 1986 Sep; 113(1):23-8. PubMed ID: 2876570
[TBL] [Abstract][Full Text] [Related]
11. Use of octreotide acetate for control of symptoms in patients with islet cell tumors.
Maton PN
World J Surg; 1993; 17(4):504-10. PubMed ID: 8395751
[TBL] [Abstract][Full Text] [Related]
12. [Somatostatin analog (octreotide) in clinical use: current and potential indications].
Meier R; Dierdorf R; Gyr K
Schweiz Med Wochenschr; 1992 Jun; 122(25):957-68. PubMed ID: 1621078
[TBL] [Abstract][Full Text] [Related]
13. A case of somatostatinoma: responses to food and SMS 201-995 administration.
Davis TM; Bray G; Domin J; Bloom SR
Pancreas; 1988; 3(6):729-33. PubMed ID: 2906126
[TBL] [Abstract][Full Text] [Related]
14. Shrinkage of a primary thyrotropin-secreting pituitary adenoma treated with the long-acting somatostatin analogue octreotide (SMS 201-995).
Warnet A; Lajeunie E; Gelbert F; Duet M; Chanson P; Cophignon J; Harris AG
Acta Endocrinol (Copenh); 1991 Apr; 124(4):487-91. PubMed ID: 2031445
[TBL] [Abstract][Full Text] [Related]
15. Octreotide: a somatostatin analog.
Salman K; Rose LI
Am Fam Physician; 1989 Jun; 39(6):207-11. PubMed ID: 2543196
[No Abstract] [Full Text] [Related]
16. [Novel pharmacologic therapies in acromegaly].
Góth M; Hubina E; Kovács L; Szabolcs I
Orv Hetil; 2002 May; 143(19 Suppl):1057-62. PubMed ID: 12063860
[TBL] [Abstract][Full Text] [Related]
17. [Somatostatin analogue in the treatment of neuroendocrine gut tumors].
Ben Yosef R; Glaser B; Catane R
Harefuah; 1990 Jul; 119(1-2):15-8. PubMed ID: 2172125
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future.
Öberg K; Lamberts SW
Endocr Relat Cancer; 2016 Dec; 23(12):R551-R566. PubMed ID: 27697899
[TBL] [Abstract][Full Text] [Related]
19. Role of a long-acting somatostatin analogue (SMS 201-995) in the treatment of acromegaly.
Jackson IM; Barnard LB; Lamberton P
Am J Med; 1986 Dec; 81(6B):94-101. PubMed ID: 2879453
[TBL] [Abstract][Full Text] [Related]
20. [Somatostatin and its analogs in the treatment of gastrointestinal and liver diseases].
Feu F; Bosch J
Gastroenterol Hepatol; 1996 Feb; 19(2):68-77. PubMed ID: 8616683
[No Abstract] [Full Text] [Related]
[Next] [New Search]
